A molecular diagnostic test for BCR-ABL fusion gene detection in chronic myeloid leukemia and acute lymphoblastic leukemia.
Manufactured by
Daejeon, South Korea
PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics. We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories. (EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. (HPV, STD, CRE, TB/NTM) Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user. The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings. (Viral, FFPE, cfDNA extraction kits) PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products. We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GMA Group Trading
Egypt · 2 relevant products
TRUPCR Europe Ltd
United Kingdom · 23 relevant products
Diatech Pharmacogenetics srl
Italy · 1 relevant product
AB ANALITICA Srl
Italy · 5 relevant products
Operon S.A.
Spain · 2 relevant products
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Medix Biochemica Oy AB
Finland · 3 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 1 relevant product
Genesystem Co., Ltd.
South Korea · 1 relevant product
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 100 closest product alternatives
GMA Group Trading · Egypt
Real-time PCR test for detection and quantification of BCR-ABL fusion transcripts in chronic myeloid leukemia.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for qualitative detection of BCR-ABL fusion transcripts. This kit enables detection of BCR-ABL1 presence for initial diagnosis of chronic myeloid leukemia.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for quantitative measurement of BCR-ABL fusion transcripts. This kit provides absolute quantification of BCR-ABL1 levels for disease monitoring and therapeutic response assessment in chronic myeloid leukemia.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for screening and detection of BCR-ABL1 fusion transcripts. This kit is designed for initial identification of BCR-ABL1 in suspected chronic myeloid leukemia cases.
AB ANALITICA Srl · Italy
A molecular diagnostic test for BCR-ABL fusion gene detection. This test is used in onco-hematology for chronic myeloid leukemia (CML) diagnosis and monitoring.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for differentiation of BCR-ABL1 fusion transcript variants b2a2 and b3a2. This kit enables identification of specific BCR-ABL1 breakpoint variants relevant to chronic myeloid leukemia diagnosis.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for detection of BCR-ABL1 with EAC-DEL variant status. This kit identifies specific BCR-ABL1 deletion variants relevant to chronic myeloid leukemia diagnosis and prognosis.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for differentiation of BCR-ABL1 transcript variants. This kit enables classification of BCR-ABL1 breakpoint types relevant to chronic myeloid leukemia characterization.
TRUPCR Europe Ltd · United Kingdom
A digital PCR-based diagnostic test kit for detection of major BCR-ABL1 fusion transcripts. This kit provides sensitive and specific quantification of BCR-ABL1 levels using digital polymerase chain reaction technology.
AB ANALITICA Srl · Italy
A molecular diagnostic test for PML-RARa fusion gene (BCR2 variant) detection. This test is used in onco-hematology for acute promyelocytic leukemia (APL) diagnosis.
TRUPCR Europe Ltd · United Kingdom
A digital PCR-based diagnostic test for BCR-ABL1 fusion gene detection and quantification. This kit provides sensitive and absolute quantification of BCR-ABL1 transcripts using digital polymerase chain reaction technology.
88 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products